Pharmaceutical Executive-04-01-2019

Pharmaceutical Executive

Follow-on product naming, messaging challenge FDA, industry.

Pharmaceutical Executive
Features

April 07, 2019

Sharon Callahan, this year’s Healthcare Businesswomen’s Association Woman of the Year, has built a career defined by an entrepreneurial drive to advance medical communications-and a commitment to breaking down barriers in the workplace and beyond.

Pharmaceutical Executive
From the Editor

April 07, 2019

The lifeblood of our coverage are the many interviews we conduct with industry executives-and the unique stories and insights they provide. Here, I highlight excerpts from a selection of wide-ranging conversations from the past year.

Europe slow to action on emerging technologies, but the complex issues clouding EHRs and gene editing, for example, offer pause.

Pharmaceutical Executive

One company’s approach to recruiting and managing talent in an increasingly competitive marketplace.

Pharmaceutical Executive

Thinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm.

Pharmaceutical Executive
Features

April 05, 2019

Nine ways pharma companies can maximize a CDO’s potential value and impact on driving innovation as a business mandate.

Pharmaceutical Executive

Despite being the fastest growing influencers in healthcare, ad campaigns targeted at payers are often an afterthought.

Features
Pharmaceutical Executive

April 01, 2019

How gamification can help pharma play to win.

Issue PDF
Pharmaceutical Executive

April 01, 2019

Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.

Special Sponsored Section
Pharmaceutical Executive

April 01, 2019

Declaring it a “strategic sector for priority development,” China has opened up the floodgates for sweeping reforms of the nation’s healthcare infrastructure-a watershed moment for the Chinese pharmaceutical and healthcare industries, where all stakeholders will have to adapt to the new rules of the game.